Insulet (PODD) Reaches $52.02 52-Week High, Shorts at Soleno Therapeutics (SLNO) Lowered By 6.99%

July 21, 2017 - By Nellie Frank

The stock of Insulet Corporation (NASDAQ:PODD) hit a new 52-week high and has $56.18 target or 8.00% above today’s $52.02 share price. The 8 months bullish chart indicates low risk for the $3.05 billion company. The 1-year high was reported on Jul, 21 by Barchart.com. If the $56.18 price target is reached, the company will be worth $244.00M more. About 246,907 shares traded. Insulet Corporation (NASDAQ:PODD) has risen 48.83% since July 21, 2016 and is uptrending. It has outperformed by 32.13% the S&P500.

Soleno Therapeutics Incorporated (NASDAQ:SLNO) had a decrease of 6.99% in short interest. SLNO’s SI was 174,200 shares in July as released by FINRA. Its down 6.99% from 187,300 shares previously. With 14,000 avg volume, 12 days are for Soleno Therapeutics Incorporated (NASDAQ:SLNO)’s short sellers to cover SLNO’s short positions. About 1,490 shares traded. Soleno Therapeutics Inc (NASDAQ:SLNO) has 0.00% since July 21, 2016 and is . It has underperformed by 16.70% the S&P500.

Soleno Therapeutics, Inc., formerly Capnia, Inc., is a healthcare firm that develops and commercializes neonatology devices and diagnostics. The company has market cap of $32.69 million. The Firm also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. It currently has negative earnings. The Firm offers products, such as CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief.

Since March 2, 2017, it had 3 buys, and 4 sales for $3.48 million activity. Spears Michael P bought $101,470 worth of stock or 2,500 shares. SOMMER REGINA O also sold $1.80 million worth of Insulet Corporation (NASDAQ:PODD) on Monday, March 13. Lemoine David A sold $66,142 worth of Insulet Corporation (NASDAQ:PODD) on Monday, May 1. The insider Zakrzewski Joseph S sold 40,000 shares worth $1.87 million. The insider Hopfield Jessica bought $99,783. $116,077 worth of stock was bought by Thomas Bradley A on Thursday, May 11.

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System , an insulin delivery system for people with insulin-dependent diabetes. The company has market cap of $3.05 billion. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximately three days at a time and its wireless companion, the handheld Personal Diabetes Manager (PDM). It currently has negative earnings. The Omnipod System features two discreet devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter.

Analysts await Insulet Corporation (NASDAQ:PODD) to report earnings on August, 3 after the close. They expect $-0.13 EPS, down 62.50% or $0.05 from last year’s $-0.08 per share. After $-0.17 actual EPS reported by Insulet Corporation for the previous quarter, Wall Street now forecasts -23.53% EPS growth.

Investors sentiment decreased to 0.87 in Q4 2016. Its down 0.25, from 1.12 in 2016Q3. It dived, as 26 investors sold Insulet Corporation shares while 58 reduced holdings. 21 funds opened positions while 52 raised stakes. 60.26 million shares or 0.42% more from 60.00 million shares in 2016Q3 were reported. State Bank Of America De accumulated 0% or 139,969 shares. Blackrock Japan holds 0% or 1,320 shares in its portfolio. Blackrock Inv Ltd Llc holds 0.01% or 253,633 shares in its portfolio. Cantab Prns Ltd Liability Partnership, a United Kingdom-based fund reported 3,791 shares. Deutsche National Bank Ag accumulated 164,131 shares. Tiaa Cref Invest Ltd Com has 0% invested in Insulet Corporation (NASDAQ:PODD). Frontier Mngmt Ltd Llc stated it has 0.46% of its portfolio in Insulet Corporation (NASDAQ:PODD). California State Teachers Retirement Sys accumulated 0.01% or 118,969 shares. Axa accumulated 134,078 shares. Gru One Trading Ltd Partnership reported 6,126 shares. Jennison Assocs Ltd Limited Liability Company has invested 0% in Insulet Corporation (NASDAQ:PODD). Financial Bank Of Nova Scotia reported 42,393 shares. Moreover, Proshare Limited Liability Corp has 0% invested in Insulet Corporation (NASDAQ:PODD) for 9,266 shares. Geneva stated it has 20,825 shares or 0.02% of all its holdings. Ny State Common Retirement Fund holds 72,650 shares.

Among 12 analysts covering Insulet Corporation (NASDAQ:PODD), 6 have Buy rating, 1 Sell and 5 Hold. Therefore 50% are positive. Insulet Corporation has $50 highest and $15 lowest target. $40.10’s average target is -22.91% below currents $52.02 stock price. Insulet Corporation had 23 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was upgraded by Robert W. Baird to “Outperform” on Friday, January 6. The stock has “Outperform” rating by William Blair on Friday, April 29. The firm has “Hold” rating given on Monday, July 17 by BTIG Research. Jefferies maintained the stock with “Buy” rating in Thursday, July 13 report. On Monday, November 2 the stock rating was initiated by Morgan Stanley with “Equal-Weight”. Empire initiated the shares of PODD in report on Thursday, February 25 with “Sell” rating. Benchmark upgraded Insulet Corporation (NASDAQ:PODD) on Friday, February 26 to “Buy” rating. The stock of Insulet Corporation (NASDAQ:PODD) earned “Outperform” rating by Wedbush on Tuesday, February 28. The firm has “Buy” rating given on Thursday, August 4 by Jefferies. The rating was maintained by Northland Capital with “Outperform” on Friday, November 6.